poisar

Stocks · News reference

Burning Rock Biotech Q2 EPS $(0.20) Down From $(0.10) YoY, Sales $19.862M Down From $20.737M YoY

BenzingaBenzinga Newsdesk

Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.20) per share. This is a 100 percent decrease over losses of $(0.10) per share from the same period last year. The company reported $19.862 million in

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Fiscal.ai

    Brenntag SE Q3 2026 Earnings Preview

    Analysts have released their earnings forecasts for Brenntag SE ahead of the company's scheduled third-quarter 2026 financial results announcement on November 11, 2026.